These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

198 related items for PubMed ID: 19845263

  • 1. [Prognostic significance of the Mandard TRG classification after induction therapy in carcinoma of the oesophagus and cardia].
    Zanoni A, Verlatoa G, Minicozzi A, Tomezzoli A, Giacopuzzi S, Di Cosmo M, Franceschetti I, Saladino E, De Manzoni G.
    Chir Ital; 2009; 61(4):419-25. PubMed ID: 19845263
    [Abstract] [Full Text] [Related]

  • 2. Response to induction therapy in oesophageal and cardia carcinoma using Mandard tumour regression grade or size of residual foci.
    Verlato G, Zanoni A, Tomezzoli A, Minicozzi A, Giacopuzzi S, Di Cosmo M, Franceschetti I, de Manzoni G.
    Br J Surg; 2010 May; 97(5):719-25. PubMed ID: 20306529
    [Abstract] [Full Text] [Related]

  • 3. A simplified tumor regression grade correlates with survival in locally advanced rectal carcinoma treated with neoadjuvant chemoradiotherapy.
    Beddy D, Hyland JM, Winter DC, Lim C, White A, Moriarty M, Armstrong J, Fennelly D, Gibbons D, Sheahan K.
    Ann Surg Oncol; 2008 Dec; 15(12):3471-7. PubMed ID: 18846402
    [Abstract] [Full Text] [Related]

  • 4. Pretreatment T3-4 stage is an adverse prognostic factor in patients with esophageal squamous cell carcinoma who achieve pathological complete response following preoperative chemoradiotherapy.
    Chao YK, Chan SC, Liu YH, Chen HW, Wan YL, Chang HK, Fan KH, Liu HP.
    Ann Surg; 2009 Mar; 249(3):392-6. PubMed ID: 19247024
    [Abstract] [Full Text] [Related]

  • 5. Patient demographics and lifestyle factors influencing long-term survival of oesophageal cancer and gastric cardia cancer in a nationwide study in Sweden.
    Sundelöf M, Lagergren J, Ye W.
    Eur J Cancer; 2008 Jul; 44(11):1566-71. PubMed ID: 18434132
    [Abstract] [Full Text] [Related]

  • 6. [Goseki classification in adenocarcinoma of the cardia].
    De Manzoni G, Pedrazzani C, Di Leo A, Bonfiglio M, Zerman G, Tasselli S, Borzellino G.
    Minerva Chir; 2002 Aug; 57(4):449-55. PubMed ID: 12145574
    [Abstract] [Full Text] [Related]

  • 7. Adenocarcinoma of the Esophagogastric Junction in China according to Siewert's classification.
    Bai JG, Lv Y, Dang CX.
    Jpn J Clin Oncol; 2006 Jun; 36(6):364-7. PubMed ID: 16766566
    [Abstract] [Full Text] [Related]

  • 8. 101 oesophageal cancers: a surgeon uses radiotherapy.
    Earlam RJ, Johnson L.
    Ann R Coll Surg Engl; 1990 Jan; 72(1):32-40. PubMed ID: 1689132
    [Abstract] [Full Text] [Related]

  • 9. The influence of surgical volume on hospital mortality and 5-year survival for carcinoma of the oesophagus and gastric cardia.
    Wenner J, Zilling T, Bladström A, Alvegård TA.
    Anticancer Res; 2005 Jan; 25(1B):419-24. PubMed ID: 15816605
    [Abstract] [Full Text] [Related]

  • 10. Effects of preoperative chemoradiotherapy on postsurgical morbidity and mortality in cT3-4 +/- cM1lymph cancer of the oesophagus and gastro-oesophageal junction.
    Hagry O, Coosemans W, De Leyn P, Nafteux P, Van Raemdonck D, Van Cutsem E, Hausterman K, Lerut T.
    Eur J Cardiothorac Surg; 2003 Aug; 24(2):179-86; discussion 186. PubMed ID: 12895604
    [Abstract] [Full Text] [Related]

  • 11. [Survival prognostic factors in a cohort of patients with esophageal carcinoma].
    Navarrete Alemán J, Oñate Ocaña LF, Herrera Goepfert R, Moreno Varaona JZ, Mondragón Sánchez R, Aiello Crocifoglio V.
    Rev Gastroenterol Mex; 2004 Aug; 69(4):209-16. PubMed ID: 15765972
    [Abstract] [Full Text] [Related]

  • 12. Classification of pathologic response to neoadjuvant therapy in esophageal and junctional cancer: assessment of existing measures and proposal of a novel 3-point standard.
    Donohoe CL, O'Farrell NJ, Grant T, King S, Clarke L, Muldoon C, Reynolds JV.
    Ann Surg; 2013 Nov; 258(5):784-92; discussion 792. PubMed ID: 24045450
    [Abstract] [Full Text] [Related]

  • 13. Surgical treatment of carcinoma of the oesophagus and cardia.
    Appelqvist P, Mattila S, Jyrälä A, Tala P.
    Scand J Thorac Cardiovasc Surg; 1977 Nov; 11(3):278-82. PubMed ID: 594725
    [Abstract] [Full Text] [Related]

  • 14. A preliminary study on the postoperative survival of patients given aspirin after resection for squamous cell carcinoma of the esophagus or adenocarcinoma of the cardia.
    Liu JF, Jamieson GG, Wu TC, Zhu GJ, Drew PA.
    Ann Surg Oncol; 2009 May; 16(5):1397-402. PubMed ID: 19241108
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Proposal for a new definition of true cardia carcinoma.
    Ichikura T, Chochi K, Sugasawa H, Mochizuki H.
    J Surg Oncol; 2007 Jun 01; 95(7):561-6. PubMed ID: 17192914
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Disparities in the classification of esophageal and cardia adenocarcinomas and their influence on reported incidence rates.
    Lindblad M, Ye W, Lindgren A, Lagergren J.
    Ann Surg; 2006 Apr 01; 243(4):479-85. PubMed ID: 16552198
    [Abstract] [Full Text] [Related]

  • 19. Excellent interobserver agreement on grading the extent of residual carcinoma after preoperative chemoradiation in esophageal and esophagogastric junction carcinoma: a reliable predictor for patient outcome.
    Wu TT, Chirieac LR, Abraham SC, Krasinskas AM, Wang H, Rashid A, Correa AM, Hofstetter WL, Ajani JA, Swisher SG.
    Am J Surg Pathol; 2007 Jan 01; 31(1):58-64. PubMed ID: 17197919
    [Abstract] [Full Text] [Related]

  • 20. Concurrent chemotherapy and radiation therapy followed by transhiatal esophagectomy for local-regional cancer of the esophagus.
    Forastiere AA, Orringer MB, Perez-Tamayo C, Urba SG, Husted S, Takasugi BJ, Zahurak M.
    J Clin Oncol; 1990 Jan 01; 8(1):119-27. PubMed ID: 2295902
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.